Bryn Pharma
Bryn Pharma is dedicated to creating innovative, affordable, and easy-to-use solutions for managing severe allergies and anaphylaxis. Founded by patients affected by anaphylaxis, the company aims to develop needle-free, portable, and accessible epinephrine delivery systems, including nasal sprays, to improve patient outcomes and address current treatment gaps.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Intranasal epinephrine spray device under development
A needle‑free, portable intranasal epinephrine product using a two‑spray (bi‑dose) nasal delivery system intended for outpatient emergency treatment of anaphylaxis; currently in clinical development and not approved by regulatory authorities.
Intranasal epinephrine spray device under development
A needle‑free, portable intranasal epinephrine product using a two‑spray (bi‑dose) nasal delivery system intended for outpatient emergency treatment of anaphylaxis; currently in clinical development and not approved by regulatory authorities.
Services
Engagement with external partners for development, investment, and commercialization collaborations.
Engagement with external partners for development, investment, and commercialization collaborations.
Expertise Areas
- Clinical trial management and operations
- Pharmacokinetics and pharmacodynamics (PK/PD) analysis
- Intranasal drug delivery and device development
- Preclinical animal model evaluation
Key Technologies
- Intranasal drug delivery (bi‑dose nasal spray)
- Nasal formulation development
- PK/PD analysis
- Crossover and dose‑ranging clinical trial designs
News & Updates
Bryn Pharma is working on a new nasal spray for epinephrine as an alternative to auto-injectors, aiming to improve portability, accessibility, and ease of use for allergy sufferers.
Bryn Pharma is working on a new nasal spray for epinephrine as an alternative to auto-injectors, aiming to improve portability, accessibility, and ease of use for allergy sufferers.